Codi QR

Personalized assessment of hyperuricemia probability in metabolic dysfunction-associated steatotic liver disease: construction and multicenter validation of a clinical nomogram

Abstract Background Metabolic dysfunction-associated steatotic liver disease is increasingly recognized as a precursor to secondary hyperuricemia, significantly exacerbating metabolic burden. However, reliable tools for early risk stratification in MASLD patients remain limited. This study aimed to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yahui Wu, Jinsheng Wang, Yixiang Xing, Min Kang, Xiaoqing Yuan, Yun Shen
Format: Artigo
Idioma:Inglês
Publicat: BMC 2026-05-01
Col·lecció:BMC Gastroenterology
Matèries:
Accés en línia:https://doi.org/10.1186/s12876-026-04844-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!